B. Martin

Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis Prediction

K. Covington, F. Monzon, P. Beitsch, 2021, JCO precision oncology.

The 31-gene expression profile stratifies recurrence and metastasis risk in patients with cutaneous melanoma.

K. Dillon, R. Cook, A. Quick, 2021, Future oncology.

Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study

K. Covington, J. Vetto, O. Zolochevska, 2022, Current medical research and opinion.

Improved cutaneous melanoma survival stratification through integration of 31-gene expression profile testing with the American Joint Committee on Cancer 8th Edition Staging

J. J. Siegel, D. Rigel, K. Covington, 2022, Melanoma research.

Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I–II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study

S. Puig, A. Boada, R. Cook, 2022, Cancers.

31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER Collaboration.

M. Schymura, K. Covington, R. Cress, 2023, JCO precision oncology.

The Integrated i31-GEP Test Outperforms the MSKCC Nomogram at Predicting SLN Status in Melanoma Patients

B. Martin, Michael Tassavor, Alex M. Glazer, 2023, AntiCancer Research.